Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? Against (Q43971537)

28 November 2017

title

Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? Against (English)

1 reference

28 November 2017

1 reference

Kirk A Frey

1

1 reference

28 November 2017

publication date

22 March 2002

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

28 November 2017

published in

1 reference

28 November 2017

volume

29

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

715-717

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-002-0815-4

28 November 2017

exact match

0 references

cites work

Dopa decarboxylase activity of the living human brain

1 reference

https://api.crossref.org/works/10.1007%2FS00259-002-0815-4

The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-002-0815-4

Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-002-0815-4

[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-002-0815-4

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-002-0815-4

Decreased striatal dopaminergic innervation in REM sleep behavior disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-002-0815-4

In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-002-0815-4

A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Parkinson Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-002-0815-4

The vesicular monoamine transporter is not regulated by dopaminergic drug treatments

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11976814

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Regulation of dopaminergic activity in early Parkinson's disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11976814

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00259-002-0815-4

1 reference

28 November 2017

1 reference